Closed Loop Medicine is delighted to be among the twenty-eight UK HealthTech pioneers joining the ABHI trade mission to Texas.

Closed Loop Medicine joins 28 UK HealthTech pioneers on ABHI mission to strengthen trade relations in Texas

Cambridge and London, UK, 24th March 2022: Closed Loop Medicine Ltd, a leader in the development of single prescription drug plus digital therapy (DTx) combination products to enable precision dosing and care, will be joining the ABHI US trade mission in Texas.

Closed Loop Medicine is developing drug and digital therapeutic combination products centred around dose optimization, to improve outcomes for patients, support clinicians, and enable a move towards a value-based medicine proposition for health systems by delivering precision care at a population health scale.

Closed Loop Medicine is excited to be among the delegate of pioneering HealthTech companies heading to Texas as part of the first major US trade mission organised by the Association of British HealthTech Industries (ABHI) since the COVID-19 pandemic.

The visit marks the launch of a series of ABHI-led trade missions across the US as part of its flagship US Accelerator programme.

Closed Loop Medicine joins twenty-eight of the UK’s leading HealthTech innovators heading stateside to strengthen trading relationships. The week-long missions – exclusive to members of the ABHI US Accelerator – aim to provide participants with access to senior leaders, clinicians and procurement teams from world-class hospital systems across the country, supporting them in engaging the right stakeholders and gaining valuable market insight.

Taking place from 27 March to 1 April, the Texas visit will provide a prime opportunity to forge more personal and lasting ties with the network of leaders and hospital systems ABHI has cultivated in Texas over the years and aims to generate further demand for UK-developed products.

The cohort of companies will be showcasing a range of UK HealthTech products and solutions as part of the mission, and to further demonstrate the strengths of the UK, a number of key clinical and academic figures will be joining the mission.

To enhance peer-to-peer learning and further strengthen international collaboration between respective health systems, UK leaders joining the delegation include Professor Tony Young, National Clinical Lead for Innovation at NHS England, Professor David Jayne, Professor of Surgery at the University of Leeds & Co-Director of the Leeds Centre for HealthTech Innovation (CHTI), and Dr Neville Young, Director of Enterprise & Innovation at the Academic Health Science Network.

Throughout the week, members will participate in a series of meetings, networking events and introductions across Austin, Fort Worth, Dallas, and Houston – four of the biggest cities in Texas.

Dr Myles Furnace, Commercial Vice President of Closed Loop Medicine commented: “Closed Loop Medicine is delighted to be among the twenty-eight UK HealthTech pioneers joining the ABHI trade mission to Texas. The trade mission will support our efforts to enter the US market and explore clinical collaboration opportunities for our lead hypertension program. We look forward to meeting clinical leaders face-to-face and furthering our mission to strengthen relationships with key stakeholders in the US.”

Centred in Texas, the ABHI US Accelerator is delivered in partnership with the Dell Medical School, one of the United States’ most pioneering academic institutions, based at the University of Texas, in Austin. Using the state as a springboard to other key states, the programme offers nationwide support, drawing on the relationships and connections built up across the US.

Texas is renowned as an economic powerhouse. It has the second largest GDP of any US State at 1.7 trillion dollars and were it a sovereign country, would be ranked as the 12th largest economy in the world by GDP.

Throughout the year, Closed Loop Medicine – will also take part in missions to other key states, including California, Tennessee, Minnesota, and Florida – a major state for HealthTech companies entering the US Market – and New York, another East Coast powerhouse.

Paul Benton, Managing Director, International, ABHI commented: “With regional headquarters of some of the country’s largest healthcare providers located in the State, Texas provides tangible
opportunities to UK companies and acts as the perfect springboard for them to access the wider United States. Our mission targets senior leaders across many of the main hospital systems in the State and offers unprecedented access to key decision makers and leaders. We are keen to be heading back to Texas following a brief hiatus, and we look forward to supporting our companies in exploring collaborative opportunities in the US and strengthening their partnerships.”


For further information please contact:

Closed Loop Medicine
Dr Hakim Yadi OBE, Chief Executive Officer

About Closed Loop Medicine (

Closed Loop Medicine is a global leader in the development of single prescription drug plus digital therapy (DTx) combination products, developed to optimise dosing on an individual level with linked behaviour therapy, aiming to improve patient outcomes.

Since it was founded in 2017, Closed Loop Medicine has raised over £22 million (c. £$30 million). The Company’s investors include Ananda Impact Ventures, BGF, LifeArc, Longwall, Meltwind, IQ Capital, Downing Ventures and Cambridge Angels.

Closed Loop Medicine has two products in development, one for hypertension and another for insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases, with both patient and clinician at the centre of the Company’s product design and development.


About ABHI

ABHI is the UK’s leading industry association for health technology (HealthTech). ABHI supports the HealthTech community to save and enhance lives. Members, including both multinationals and small and medium sized enterprises (SMEs), supply products from syringes and wound dressings to surgical robots and digitally enhanced technologies. We represent the industry to stakeholders, such as the government, NHS and regulators. HealthTech plays a key role in supporting delivery of healthcare and is a significant contributor to the UK’s economic growth. HealthTech is now the largest employer in the broader Life Sciences sector, employing 138,100 people in 4,140 companies, with a combined turnover of £27.6bn. The industry has enjoyed growth of around 5% in recent years. ABHI’s 320 members account for approximately 80% of the sector by value.